Business Wire

Japan's 16 Most Mesmerizing Destinations Introduced in a New Live-Action 360-Degree Video


Japan National Tourism Organization (JNTO, London Office) released a 360-degree VR video “[360-degree VR] JAPAN – Where tradition meets the future” on 16 January 2018. The video visualizing the essence of Japan and its culture was created as part of “JAPAN – Where tradition meets the future”, a large-scale inbound tourism promotion targeting 15 European countries, which started in 2016. With the concept of fusing together “tradition,” “innovation,” and “nature” which coexist in the diverse culture of Japan, the 360-degree VR video takes viewers on a virtual tour of Japan.

This press release features multimedia. View the full release here:

Japan National Tourism Organization's large-scale inbound tourism campaign "JAPAN - Where tradition  ...

Japan National Tourism Organization's large-scale inbound tourism campaign "JAPAN - Where tradition meets the future" (Photo: Business Wire)

As part of the promotion, there will be a social media prize competition to win a round-trip to Japan. Also, an AR digital signage display “Interactive Vision” will be exhibited in five countries across Europe, allowing passersby to virtually try on traditional Japanese costumes such as kabuki, maiko, and samurai.

With the aim of Japan becoming more recognized and being chosen as a tourist destination, this promotion combines “traditional culture” with “innovative technology” to create contents that will appeal to the world, as stated in the promotion title “JAPAN – Where tradition meets the future.”

About the 2018 promotion for “JAPAN – Where tradition meets the future”

“JAPAN – Where tradition meets the future,” is a highly acclaimed large-scale inbound tourism promotion by JNTO which began in 2016. The first video exceeded 13 million total views throughout the world, and has won silver and bronze in the Digital Craft division for SPIKES ASIA 2017, as well as being chosen as a finalist in three categories in ONE SHOW 2017. The 2018 promotion will provide interactive contents which will allow viewers to better understand Japan and its culture.

360-degree VR video “[360-degree VR] JAPAN – Where tradition meets the future”

This 360-degree VR video shows the mesmerizing qualities of Japan condensed into a three minute video. This video creates a simulated experience of visiting Japan, introducing 16 carefully selected tourist destinations. These include the Tokyo Tower and Kyoto’s Sagano Bamboo Forest, known as the Golden Route, and other popular tourist destinations. Passing through the torii gates of Fushimi Inari Shrine in Kyoto, viewers will find themselves in the bustle of Shibuya Scramble Crossing, as well as having a kabuki actor perform right before their eyes. The video also includes points of views not very common in 360-degree VR videos such as being at eye-level with a Prize Pikachu from the claw machine, Sushi on a conveyor-belt, and a parfait on top of a tray at KAWAII MONSTER CAFE HARAJUKU.

Prize Competition

Along with the video release, there will be a prize competition “WIN A TRIP TO JAPAN!” Participants are asked to watch the promotional video “[360-degree VR] JAPAN - Where tradition meets the future” on the JNTO official Facebook page and post comments about their most memorable scenes. One winner from each of the five countries will be awarded a pair of round-trip air tickets to Japan.
*Viewers from France can also participate by following the JNTO Paris official Twitter account and retweeting the “#visitjapan” tweet.

Schedule: Wednesday, 17 January 2018 2:00PM - Friday, 2 March 2018 2:00PM (Japan Time)
Exhibition country: Spain, France, UK, Italy, Germany
Prize: Round-trip air ticket to Japan (one pair per country)
*For more information, please refer to the campaign website (

AR Digital Signage Display “Interactive Vision”

From Thursday, 18 January 2018 – Wednesday, 28 February 2018, an AR Digital Signage Display “Interactive Vision” where passersby can virtually try on Japanese traditional costumes, will be exhibited in five countries across Europe. The countries where the signage display will be exhibited are Spain (Madrid), France (Paris), UK (London), Italy (Milan), and Germany (Munich, Frankfurt), at major stations, shopping malls, etc. for four - five days per country.

Contact information

JNTO "Japan - Where tradition meets the future" PR Head Office @ AUR, Inc.
Misato Kagami, Ashita Iju, +81-3-5545-3888
*Please contact us by e-mail.

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

Seoul Semiconductor’s SunLike Series LEDs Win Product of the Year Award from Elektronik Magazine23.3.2018 18:28Pressemelding

Seoul Semiconductor, a global innovator of LED products and technology, announced on March 23rd that its SunLike Series natural spectrum LED product won the Gold Award at the Elektronik Product of the Year 2018 Awards, hosted by Elektronik (, a leading German electronics publication. This press release features multimedia. View the full release here: Product of the Year Award from Elektronik Magazine (SunLike) (Photo: Business Wire) As a publication specializing in electrical and electronic components, “Elektronik” is a prestigious magazine with an illustrious history and the largest number of subscribers in Germany. Over the past 20 years, they have conducted annual surveys among their subscribers to find the “most creative and innovative products.” Based on these survey results, Elektronik selects the top product that with the most impact in its corresponding field, and confers the awards accordingl

Elliott Welcomes Imminent Bezeq Board Overhaul and New Era for Strong Independent Governance23.3.2018 16:05Pressemelding

Elliott Advisors (UK) Limited (“Elliott”), which advises funds which collectively hold a significant economic interest in Bezeq The Israeli Telecommunication Corporation Ltd. (“Bezeq” or the “Company”), welcomes the proposed governance reforms announced by Bezeq last night. In its initial letter to Bezeq Interim Chairman David Granot, dated January 16, 2018, Elliott outlined the urgent need to address the Company’s serious corporate governance issues, and called for changes at the Board level that result in “the right mixture of expertise, independence and integrity for the future.” Elliott stated then, and reiterates now, its belief that “there is significant value to be unlocked if the right steps are taken to improve its corporate governance.” Bezeq has strong business fundamentals, an exemplary workforce, and great potential. Following yesterday’s announcement, Elliott highlights the changes that have occurred since January 16th. Taken together, these amount to a revolution in the

Clovis Oncology Initiates Early Access Program for Rucaparib as Treatment and as Maintenance Therapy in Recurrent Ovarian Cancer in Europe23.3.2018 12:52Pressemelding

Clovis Oncology, Inc. (NASDAQ:CLVS) today announced the initiation of an early access program in Europe for rucaparib for treatment and as maintenance therapy in recurrent ovarian cancer. The program will be overseen and implemented by Caligor Coghlan, which specializes in early access to medicines. The program, to be known as the Rucaparib Access Program (RAP), will enable participation from certain countries in Europe, where permitted by applicable rules, procedures and regulatory authorities. The RAP protocol allows for rucaparib treatment of an individual patient with third-line or greater BRCA mutant epithelial, fallopian tube, or primary peritoneal ovarian cancer who has platinum-sensitive disease and is unable to tolerate further platinum-based chemotherapy or has platinum-resistant disease and needs treatment with single agent rucaparib. The RAP protocol will also provide access to rucaparib for maintenance therapy of an individual patient with recurrent epithelial ovarian, fal

CHMP Grants Positive Opinion for Clovis Oncology’s Rubraca® (rucaparib) Tablets23.3.2018 12:50Pressemelding

Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that the European Union’s (EU) European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of a conditional marketing authorization for Rubraca as monotherapy treatment of adult patients with platinum sensitive, relapsed or progressive, BRCA mutated (germline and/or somatic), high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer, who have been treated with two or more prior lines of platinum based chemotherapy, and who are unable to tolerate further platinum based chemotherapy. The European Marketing Authorization application for the treatment indication was based on objective response rate and duration of response results from two multicenter, single-arm, open-label clinical trials, Study 10 and ARIEL2, in women with advanced BRCA mutant ovarian cancer who had progressed after two or more prior chemotherapies. “The recommendation

Janssen Announces Positive CHMP Opinion for JULUCATM▼ (dolutegravir/rilpivirine)23.3.2018 12:46Pressemelding

The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a Positive Opinion recommending marketing authorisation for JULUCA™ (dolutegravir 50mg [ViiV Healthcare UK Ltd]/rilpivirine 25mg [Janssen Sciences Ireland UC]). Dolutegravir/rilpivirine is a single-pill, two-drug regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults who are virologically suppressed (HIV-1 RNA <50 c/mL) on a stable antiretroviral regimen for at least six months with no history of virological failure and no known or suspected resistance to any non-nucleoside reverse transcriptase inhibitor (NNRTI) or integrase strand transfer inhibitor (INSTI).1 “We are delighted to be one step closer to bringing JULUCA™ to people living with HIV in Europe,” said Mathai Mammen, M.D., Ph.D., Global Head, Janssen Research & Development, LLC. “Building on our 25-year c

Aitheon Executives Educate World Leaders on Benefits, Challenges of AI at the Annual World Government Summit in Dubai23.3.2018 12:00Pressemelding

Aitheon, makers of the world’s first blockchain-powered platform to solve real problems by integrating AI, robotics, IoT, human specialists and cryptocurrency, announced today that executives from the company held a series of high-level briefings with world leaders at the Annual World Government Summit in Dubai. Briefings covered the benefits and challenges of AI, and revolutionary new solutions to world challenges made possible by transformative new technologies. (Read the full release at This press release features multimedia. View the full release here: Aitheon founder and CEO, Andrew Archer, and Chief Strategy Officer, Ryan Burleson, were invited to brief leaders at the Summit by Cyrus Hodes, Co-founder and Director of the AI Initiative, an undertaking of the Future Society at Harvard University’s Kennedy School. Archer and Burleson addressed a variety of AI-related topics, including the impact of AI on